X

Lifitegrast: an alternative treatment for dry eye disease

By: Vicky Liu, PharmD Candidate c/o 2018 - On July 11, 2016, lifitegrast (Xiidra®), the first lymphocyte function-associated antigen 1…

eMAR

Goodbye pharmacists, hello robots?

By: Katherine Russo, PharmD Candidate c/o 2021 - “Treat the whole patient and not the whole in the patient”  –…

eMAR

Two hepatitis C drugs approved for pediatric use

By: Anna Diyamandoglu, PharmD Candidate c/o 2020 - Hepatitis C is an infectious disease which is caused by the hepatitis…

eMAR

The function and efficacy of pimavanserin (Nuplazid®) in the treatment of psychosis associated with Parkinson’s Disease

By: Jonathan Mercado, PharmD Candidate c/o 2019 - In April 2016, the FDA approved the first drug specifically indicated for…

eMAR

Biosimiliars: how will they affect the pharmacoeconomics of health care?

By: Kenny Chan, PharmD - Competition is the greatest driver of innovation and cost savings. The U.S. health care system…

eMAR

A review on potassium iodide in radiological disasters

By: Victoria Hom, PharmD Candidate c/o 2018 - This year marked the 31st anniversary of Chernobyl, the worst nuclear disaster…

eMAR

Rocket (Health) Science: Pharmaceutical Challenges at the Johnson Space Center

By: Kimberly Lapierre, PharmD Candidate c/o 2017 - Since its inception in 2003, the Johnson Space Center Pharmacy has taken…

eMAR

The Importance of Inhaler Education: A Comprehensive Review

By: Jack (Hongkai) Bao, PharmD Candidate c/o 2018 - Inhalers are one of the most prescribed therapies used to treat…

eMAR

2017’s Immunization Guidelines Officially Released by the CDC

By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - The release of this year's updated immunization schedule has sent a buzz…

eMAR

Stevens-Johnson Syndrome: Physiological Progression and Management

By: Omar Rahman, PharmD Candidate c/o 2017 - Stevens-Johnson Syndrome is a unique skin disease that may be due to…

eMAR